Malaria Ag Rapid Testing Market Size & Share, by Product Type (Dipsticks, Cassette); Distribution Channel (Drugstore, Retail Pharmacy, Hospital Chain Pharmacy, Online Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5547
  • Published Date: Jan 18, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Malaria Ag Rapid Testing Market size is projected to surpass USD 59 Billion by the end of 2036, growing at a CAGR of over 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of malaria ag rapid testing was USD 36 Billion. This market is poised to rise on account of the growing prevalence of malaria. According to the World Health Organization, in comparison to 244 million cases in 2021, there were a total of 249 million cases of malaria in 2022, according to the most recent World Malaria Report. The predicted number of malaria deaths stood to 608 000 in 2022 compared to 610 000 in 2021. Hence, the market demand for malaria ag rapid testing is poised to rise.

Furthermore, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae are the four different types of malaria parasites that affect humans. However, it is estimated that more different types of malaria are set to become prevalent in the coming years. Therefore, the need for malaria ag rapid testing is poised to surge in the coming years.  


Malaria Ag Rapid Testing Market
Get more information on this report: Request Free Sample PDF


Malaria Ag Rapid Testing Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~5%

Base Year Market Size (2023)

~ USD 36 Billion

Forecast Year Market Size (2036)

~ USD 59 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Malaria Ag Rapid Testing Market: Growth Drivers and Challenges

Market-Growth-Drivers

Growth Drivers

  • Surge in Adoption of Latest Technology - After the outbreak of the pandemic various technologies proved its importance in various sectors. However, healthcare was greatly benefited from the same. One of the technologies is IoT.  The main issue is to determine the kind of parasite (strains) that cause malaria in individuals, or more specifically, identifying the presence of malaria. At present, many nations with high malaria rates have either nonexistent or very inadequate surveillance systems. Furthermore, many cannot afford it even if it were available. As a result, the demand for IoT in malaria testing is rising. With the Internet of things, every person who is a health volunteer in a tiny village might simply collect a blood sample and get an answer concerning the presence of the malaria parasite without needing any understanding of detecting parasites.
  • Rise in Government Initiatives for Awareness Regarding Malaria  - A vital factor in the successful eradication of malaria was health promotion and education. Programmes to raise awareness of malaria have an important effect on health promotion as they improve health-related behaviors and raise awareness of the disease while additionally promoting social support and inter-sectoral cooperation. For instance, Mission Zero Malaria, which has been launched in collaboration with Malaria No More as an implementation partner, is in line with India's 2030 elimination of malaria goal. Its objective is to raise health awareness and encourage the adoption of desired behavior changes within the community, health system, and government bodies in the region.
  • Extreme Weather Events to Increase the Prevalence of Malaria   - Severe weather conditions including heat waves and flooding can also have an immediate effect on the burden of disease and its spread. There is growing evidence connecting the spread of malaria to climate change, and certain experts predict that unless considerable steps are taken to combat climate change, malaria transmission will continue to rise globally. For instance, Pakistan experienced catastrophic flooding in 2022, leading to the number of malaria infections rising five-fold. Concurrently, it is believed that additional environmental modifications, such as deforestation, may influence mosquito dispersal patterns and, consequently, the transmission of diseases transmitted by mosquitoes.

Challenges

  • Lack of Awareness Regarding Malaria Among People
  • Lack of Efficiency of Test
  • Lack of Adoption of Technology - The lack of clear demand for improved goods and tiny profit margins make it difficult to provide incentives to encourage malaria RDT innovation. The latest developments in malaria RDT are mostly supported by donors, and they move slowly. Prequalified testing is particularly critical for scenarios where HRP2/3 deletions have occurred. Manufacturers lack access to trustworthy information about the rate at which deletions will spread, the nations that will probably need new testing or the methods that procurers will use to handle these tests (e.g., pricing, sourcing based on product differentiation). Hence, the market is set to be hindered over the forecast period.


Malaria Ag Rapid Testing Segmentation

Distribution Channel (Drugstore, Retail Pharmacy, Hospital Chain Pharmacy, Online Pharmacy)

The hospital chain pharmacy segment in the malaria ag rapid testing market is set to gather the highest share of about 40% during the forecast period. This growth is set to be influenced by growth in number of hospitals. The number of hospitals worldwide as of 2021 is estimated to be over 164,000. Hospitals serve a vital role in the struggle over malaria, given their ability to deal with a wide range of medical ailments, particularly severe cases of the illness. Since RDTs are dependable and precise, patients receive swift and accurate diagnoses in hospital settings. This is why they are preferred. In addition, hospitals frequently act as referral hubs for patients from different areas seeking care, so having access to quick and accurate diagnostic tests is crucial. Furthermore, the widespread use of hospitals and the crucial role that clinics play in treating and diagnosing malaria indicate a comprehensive approach to the disease. The collaborative effort between these healthcare settings emphasizes the need of customized diagnostic approaches for a range of end users and shows promise for more successful malaria control.

Product Type (Dipsticks, Cassette)

Malaria ag rapid testing market from the dipstick segment is estimated to gather the highest share of about 60% during the forecast period. This could be since, researchers came to the judgment that, if nonspecialized laboratories are engaged, dipsticks offer the potential to improve the specific accuracy of the diagnosis of P. falciparum malaria based on the specificity and sensitivity achieved. Furthermore, since they are portable, dipstick instruments provide on-site testing for the identification of tampered specimens. This major advantage has led to an abundance of commercially available devices. Moreover, the cost of the dipstick is relevantly low which adds to its demand. These typically entail attaching chemically treated pads to plastic strips, each pad serving as an assay for a distinct characteristic of the object. Since they are portable, dipstick instruments provide on-site testing for the identification of tampered specimens. This major advantage has led to an abundance of commercially available devices. These typically entail attaching chemically treated pads to plastic strips, each pad serving as an assay for a distinct characteristic of the object.

Our in-depth analysis of the global market includes the following segments:

          Product Type

  • Dipsticks
  • Cassette

          Distribution Channel

  • Drugstore
  • Retail Pharmacy
  • Hospital Chain Pharmacy
  • Online Pharmacy

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Malaria Ag Rapid Testing Industry - Regional Synopsis

North American Market Forecast

The North America malaria ag rapid testing market is estimated to hold 30% of the revenue share by 2036. This growth is set to be dominated by rising travelers returning to North America. Furthermore, with about 45% of US corporate travelers doing more trips than they did prior to the epidemic, business travel is returning. However, this has further led to an increase in malaria cases. Most of the people in North America visit regions such as the Middle East & Africa which is the hotspots for malaria prevalence. Hence, these travelers return back with the infection hence boosting the malaria rate. Every year, travel to malaria-endemic regions including sub-Saharan Africa, parts of South America, and Southeast Asia is linked to between 1,999 and 2,500 cases of malaria in the country; nevertheless, over 8 locally transmitted cases this year have been reported by individuals who haven't recently visited these regions. There were about 6 instances reported in Florida and one in each of Maryland and Texas. Hence, it has also been estimated that this region has recorded its first homegrown malaria cases. Therefore, the market for malaria ag rapid testing market is set to rise in this region.

European Market Analysis

The malaria ag rapid testing market in Europe is also expected to experience significant growth over the forecast period. Fifty years after being eradicated, malaria remains a serious health threat in Europe. Furthermore, there has been rigorous launch of vaccines in this region by various key players and number of researches has taken place in order to eradicate completely. As a result, this market is poised to grow in this region.

Research Nester
Malaria Ag Rapid Testing Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Malaria Ag Rapid Testing Landscape

top-features-companies
    • Wyss Institute
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Novartis AG
    • Alere, Inc.
    • Nectar Lifesciences Ltd.
    • Teco Diagnostics
    • Xiamen Boson Biotech Co. Ltd.
    • HWTAi BioTec
    • Arkray Inc.
    • CTK Biotech Inc.
    • Biosynex SA 

In-the-news

In The News

  • A multidisciplinary research team led by James Collins, Ph.D., a member of the Wyss Core Faculty at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute for Biologically Inspired Engineering, and put together by clinical fellow Rose Lee, M.D., M.S.P.H., along with Pollock and Dvorin, has developed a highly sensitive diagnostic assay that can be used in the field to identify DNA sequences from all Plasmodium species in both symptomatic and asymptomatic cases of malaria. With the help of the CRISPR-based SHERLOCK system and an optimised 10-minute quick sample preparation technique, the novel malaria diagnostic approach allows for extremely sensitive and specific Plasmodium identification in just 60 minutes using straightforward reporter devices. The publication is in PNAS.
  • In response to the growing concern of resistance to existing malaria treatments1,2, Novartis and MMV have decided to move ganaplacide/lumefantrine solid dispersion formulation (SDF) into Phase 3 development for the treatment of individuals suffering from acute, uncomplicated Plasmodium falciparum malaria.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5547
  • Published Date: Jan 18, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are surge in adoption of latest technology, rise in government initiatives for the awareness regarding malaria, and extreme weather event to increase prevalence of malaria.

The market size of malaria ag rapid testing is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2024-2036.

The major players in the market are Wyss Institute, Novartis AG, Alere, Inc., Nectar Lifesciences Ltd., and others.

The hospital chain pharmacy segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Malaria Ag Rapid Testing Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying